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ing their unfamiliarity with this new method of stem cell mobili-
zation. The patients appreciated the inpatient RN’s assistance in
this protocol but were initially dissatisﬁed with the lack of privacy
on a busy inpatient unit. A private area on the inpatient unit was
later secured for study patients to be assessed and monitored. The
administration schedule created some frustration on the part of the
patients due to the long delay between study drug injection and
apheresis. Nevertheless, accrual to this trial at our institution has
been relatively brisk. Patient education, nursing coordination, and
collaboration with members of the BMT team were paramount in
our successful implementation of this study. Designated nursing
staff committed to clinical trials, as well as detailed, mandatory
inservices need to occur in order to implement a complex BMT
trial such as this. Our experience with this trial leads us to conclude
that in order to determine whether patients may beneﬁt from novel
BMT strategies, effective nursing teamwork, education, and col-
laboration will be essential.
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REDUCING ADMISSION RATES POST-STEM CELL TRANSPLANT UTILIZ-
ING AN EDUCATIONAL QUESTIONNAIRE TO ASSESS RETENTION OF
CAREGIVER KNOWLEDGE
Chadakhtzian, A., Barnes, Y., Hayashi, R.J., Shenoy, S. 1. Saint Louis
Children’s Hospital, Saint Louis, MO; 2. Washington University School
of Medicine, Saint Louis, MO.
Background and Aim: Caregivers and recipients of stem cell
transplants (SCT) undergo an educational process to understand,
anticipate, prevent, and seek appropriate intervention for trans-
plant related medical and social issues. A quality assessment ques-
tionnaire was developed to assess retention of pediatric SCT dis-
charge education. The aim was to (1) determine the feasibility of
administering a quality assessment questionnaire following SCT
education to caregivers in pediatric SCTs and (2) correlate admin-
istration with re-admission rates in the ﬁrst 100 days post SCT.
Methods: The questionnaire was randomly introduced to a group
of 13 caregiver(s) prior to discharge. Twelve non-consecutive care-
givers served as the control group. The questionnaire consisted of
10 multiple-choice questions for autologous and 15 for allogeneic.
Questions were directed at recalling the education they received.
Upon completion, all answers were reviewed with the caregiver(s).
Any incorrect answers were reviewed and the correct answer and
rationale provided. Re-admission rates were monitored in both
groups for the ﬁrst 100 days. Results: Twenty-ﬁve patients (12
control; 13 test subjects) were analyzed during a 17 month period,
March 2004 to July 2005. Compliance was 100% in the test group.
Patient age ranged from 19 months to 17 years; there were 18
males and 7 females. The test group consisted of 2 autologous
PBSCT (peripheral blood), 2 MSD (matched sibling) BMT, 3
MSD PBSCT, and 6 URD (unrelated donor) BMT. The control
group consisted of 2 autologous PBSCT, 5 MSD PBSCT, and 5
URD BMT. The test group re-admission rate was 5/13 (38%).
The control group re-admission rate over the same period was
9/12 (75%). Staff variables between the 2 groups were similar.
Conclusions: Utilization of this tool decreased the incidence of
re-admission. This study suggests there is value in development of
a quality assessment tool assessing the impact of transplant related
education for patient caregiver(s) prior to discharge. There is a
trend toward decreased re-admissions in the early post-transplant
period and may translate into less cost, better care and comfort for
the patient. Continued assessment of this in a larger cohort is
planned over an extended period to determine the beneﬁts of this
tool.
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RECOGNIZING INDICATIONS FOR PHOTOPHERESIS IN ACUTE AND
CHRONIC GRAFT-VERSUS-HOST DISEASE PATIENTS
Graham, H.J., Wade, J.C., Rizzo, J.D., Hari, P., Miels, S.,
Gruling, R.J., Sorensen, S.H. 1. Medical College of Wisconsin, Milwau-
kee, WI; 2. M. D. Anderson, Houston, TX.
Introduction: Extra Corporal Photopheresis (ECP) is currently
being used as an effective treatment for patients with Acute and
Chronic Graft-versus-Host Disease (GVHD). Treatment has been
initiated as early as 24 hours after conﬁrming the Graft-versus-
Host Disease to be refractory to corticosteroids. Although there is
no standard treatment for Chronic Graft-versus-Host Disease,
ECP has been utilized as treatment with promising results. Meth-
ods: Cumulative treatment records for patients with Acute and
Chronic Graft-versus-Host Disease that received photopheresis
were retrospectively reviewed. Indications, frequency, and appro-
priateness of photopheresis treatment were analyzed. Although
there were indications of improvement in patients with Acute and
Chronic Graft-versus-Host Disease while receiving photopheresis
treatments, it was difﬁcult to quantify positive or negative changes
in the patients’ physical assessment. It is important to recognize
early indications of Graft-versus-Host Disease in the allogeneic
blood and marrow transplant (BMT) population. Presented is an
assessment tool to facilitate recognition and follow-up of physical
indicators in patients with Acute and Chronic Graft-versus-Host
Disease (GVHD). This assessment tool was developed following
discussions with physicians and nurses in an effort to prospectively
quantify the response to therapeutic modalities. Additionally, this
tool will assist in identifying time of response and beneﬁts of
treatments. This tool is being validated prospectively on patients
currently undergoing ECP. Once validated, the instrument will be
placed in routine use. The ultimate goal is to develop a tool to
assist the clinician in providing an initial and ongoing physical
assessment both before and during photopheresis treatment. This
tool can assist in identifying improvements or changes in the
patient’s Acute or Chronic Graft-versus-Host Disease status.
Results and conclusion will be presented.
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PERIPHERAL BLOOD CD34 ENUMERATION AS PREDICTOR FOR AU-
TOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) COLLECTION
IN CHILDREN
Daum, C.D., Klinger, E.F., Neudorf, S.M., Sloan, V., Nourani, A.,
Casacchia, C. Children’s Hospital of Orange County, Orange, CA.
Purpose: The ability to accurately predict the collection of
adequate numbers of CD34 cells in children can minimize the
unnecessary placement of apheresis catheters and stem cell collec-
tions. We hypothesize that the numbers of peripheral blood
CD34 cells will predict successful collection of HPCs in children
and are a more accurate predictor of successful collection than
white blood count. Methods: We studied 28 potential candidates
for autologous stem cell transplantation. Diseases included neuro-
blastoma (n  7), medulloblastoma (n  8), non-Hodgkin’s lym-
phoma (n  4), acute promyelocytic leukemia (n  1), other solid
tumors (n  8). The age range of the patients was 11 months–20
years. All received chemotherapy followed by 10 mcg/kg/day G-
CSF (24), or GM-CSF (1), or G-CSF  GM-CSF (2), or
G-CSF  IL-11 (1). Peripheral blood counts were monitored a
minimum of twice weekly. When the WBC 	 1000/ul, peripheral
blood CD34 cells were enumerated by ﬂow cytometry. Apheresis
was initiated when the peripheral blood CD34 count was 	10/
mm3. Apheresis was performed with the goal of collecting 5 
10e6 CD34 cells/kg. Results: Twenty-two of 28 patients had
	10 CD34 cells/ul prior to apheresis. Three patients had CD34
counts between 5-10/ul and 3 patients had CD34 counts 	5/ul.
The median CD34 count for all patients was 23.5/ul (range 2-400).
Twenty-one of 22 patients with 	10 CD34 cells/ul had had 5 
10e6 CD34 cells/kg collected and one patient reached 4.8 
10e6 CD34 cells/kg after 2 collections. Patients with 	10
CD34 cells/ul required a mean of 1.41 collections to reach the
goal of 5 10e6 CD34/kg. All patients whose CD34 count was
5-10 achieved their target goal of 5  10e6 CD34 cells/kg in a
mean of 3.33 collections. Only 1 of 3 patients with 5 CD34
cells/ul reached the goal of 5  10e6 CD34 cells/kg although in
all 3 cases, 	1  10e6 CD34 cells/kg were collected. Twenty-
eight of 28 patients had a WBC 	1000/ul prior to collection and
the WBC did not correlate with the numbers of circulating
CD34 cells. Conclusions: We found that starting apheresis
when the CD34/ul was 10 consistently resulted in meeting the
target goal of collecting 	 5  10e6 CD34 cells/kg and that
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